News

MINMON: HCV treatment achieves SVR with ‘a very minimal approach’

Despite little contact with providers, patients in a minimal monitoring scenario achieved ‘cure’ of their hepatitis C virus, according to a presentation at The Digital Liver Meeting Experience.“A very minimal approach is necessary to get a person from a diagnosis to cure,” Nancy S. Reau, MD, said in an interview with Healio. “The most important…

News

FDA grants priority review to infigratinib for cholangiocarcinoma

The FDA granted priority review designation to infigratinib for the treatment of cholangiocarcinoma, according to the agent’s manufacturer.The agency will review the application under its Real-Time Oncology Review pilot program, designed to accelerate the delivery of effective and safe cancer treatments to patients.Infigratinib (BridgeBio Pharma/QED Therapeutics) is an oral FGFR1-3 selective inhibitor in development for…

News

Stelara may be effective therapeutic for perianal Crohn’s

Stelara may be an effective therapeutic treatment in perianal refractory Crohn’s disease, according to results from the American Journal of Gastroenterology.“This large multicenter dedicated study adds substantial evidence to the growing literature on ustekinumab effectiveness in refractory CD,” Constance Chapuis-Biron, MD, from the department of gastroenterology at the University Hospital of Besançon, University Bourgogne Franche-Comté…